550 related articles for article (PubMed ID: 18368944)
1. Melatonergic drugs in clinical practice.
Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
[TBL] [Abstract][Full Text] [Related]
2. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
[TBL] [Abstract][Full Text] [Related]
3. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740
[TBL] [Abstract][Full Text] [Related]
4. The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.
Pandi-Perumal SR; Trakht I; Srinivasan V; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
World J Biol Psychiatry; 2009; 10(4 Pt 2):342-54. PubMed ID: 18609422
[TBL] [Abstract][Full Text] [Related]
5. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
Srinivasan V; Zakaria R; Othaman Z; Brzezinski A; Prasad A; Brown GM
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of melatonin agonists.
Cardinali DP; Pandi-Perumal SR; Srinivasan V; Spence DW; Trakht I
Expert Rev Endocrinol Metab; 2008 Mar; 3(2):269-279. PubMed ID: 30764095
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of depression: role of sleep and the melatonergic system.
Srinivasan V; Pandi-Perumal SR; Trakht I; Spence DW; Hardeland R; Poeggeler B; Cardinali DP
Psychiatry Res; 2009 Feb; 165(3):201-14. PubMed ID: 19181389
[TBL] [Abstract][Full Text] [Related]
8. Agomelatine in depressive disorders: its novel mechanisms of action.
Srinivasan V; Zakaria R; Othman Z; Lauterbach EC; Acuña-Castroviejo D
J Neuropsychiatry Clin Neurosci; 2012; 24(3):290-308. PubMed ID: 23037643
[TBL] [Abstract][Full Text] [Related]
9. Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.
Hardeland R; Poeggeler B
Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):189-216. PubMed ID: 22640220
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and its analogs in insomnia and depression.
Cardinali DP; Srinivasan V; Brzezinski A; Brown GM
J Pineal Res; 2012 May; 52(4):365-75. PubMed ID: 21951153
[TBL] [Abstract][Full Text] [Related]
11. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
Kasper S; Hamon M
World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
[TBL] [Abstract][Full Text] [Related]
12. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
[TBL] [Abstract][Full Text] [Related]
13. Emerging targets for the pharmacological treatment of depression: focus on melatonergic system.
Catena-Dell'Osso M; Marazziti D; Rotella F; Bellantuono C
Curr Med Chem; 2012; 19(3):428-37. PubMed ID: 22335516
[TBL] [Abstract][Full Text] [Related]
14. Ramelteon: a review of its therapeutic potential in sleep disorders.
Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
[TBL] [Abstract][Full Text] [Related]
15. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
[TBL] [Abstract][Full Text] [Related]
16. Melatonin agonists and insomnia.
Ferguson SA; Rajaratnam SM; Dawson D
Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
[TBL] [Abstract][Full Text] [Related]
17. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
[TBL] [Abstract][Full Text] [Related]
18. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
Mishima K
Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
[TBL] [Abstract][Full Text] [Related]
19. [Agomelatine: the first "melatoninergic" antidepressant].
Bánki MC
Neuropsychopharmacol Hung; 2006 Oct; 8(3):105-12. PubMed ID: 17211046
[TBL] [Abstract][Full Text] [Related]
20. [Lights off? Neurobiological and pharmacological aspects of the melatonergic-serotonergic synergism].
Sumegi A; Somoskovi C
Neuropsychopharmacol Hung; 2010 Dec; 12(4):469-75. PubMed ID: 21220792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
